BRIEF published on 10/28/2026 at 06:35, 5 days 7 hours ago Sensorion participates in the 33rd ESGCT Congress Gene Therapy Deafness SENS-601 Sensory ESGCT 2026
BRIEF published on 10/19/2026 at 10:33, 14 days 3 hours ago Sensorion appoints Peter Weber as Chief Medical Officer Appointment Gene Therapy Hearing Loss Sensory Peter Weber
BRIEF published on 10/07/2026 at 07:35, 26 days 6 hours ago Louis J. Arcudi III appointed Chief Financial Officer of Sensorion Chief Financial Officer Appointment SENS-601 Sensory Louis J. Arcudi III
PRESS RELEASE published on 10/07/2026 at 07:30, 26 days 6 hours ago Inside Information / Other news releases Sensorion appoints Louis J. Arcudi III as Chief Financial Officer. Arcudi brings extensive biopharmaceutical industry experience to the role Chief Financial Officer Biopharmaceutical Industry Financial Leadership Sensorion Louis J. Arcudi III
BRIEF published on 09/23/2026 at 07:35, 1 month 9 days ago Sensorion Reports 2026 Half-Year Results and Updates Financial Results Gene Therapy Sensorion Hearing Loss SENS-601
PRESS RELEASE published on 09/23/2026 at 07:30, 1 month 9 days ago Inside Information / News release on accounts, results Sensorion reports 2026 half-year results, provides corporate update, and announces availability of the half-year report. Progress on gene therapy programs showcased Financial Highlights Gene Therapy Clinical Trial Sensorion 2026 Results
BRIEF published on 09/18/2026 at 07:35, 1 month 14 days ago Sensorion unveils details of the SENS-601 Program Day Gene Therapy Hearing Loss SENS-601 Sensory HearConnex
PRESS RELEASE published on 09/18/2026 at 07:30, 1 month 14 days ago Inside Information / Other news releases Sensorion announces connection details for its SENS-601 Program Day on September 22, 2026, featuring Prof. Christine Petit and Dr. Sharon Cushing. Details available on the Company's website Gene Therapy Sensorion SENS-601 Program Day Connection Details
BRIEF published on 09/16/2026 at 07:35, 1 month 16 days ago Sensorion Submits Initial Public Offering Draft Biotechnology IPO SEC Filing Audiology Sensorion
BRIEF published on 09/16/2026 at 07:35, 1 month 16 days ago Sensorion is considering an initial public offering in the United States Biotechnology Initial Public Offering DRY Sensory Auditory Therapies
Published on 11/02/2026 at 14:00, 2 minutes ago GameSquare to Report Q3 2026 Financial Results on November 16, 2026
Published on 11/02/2026 at 13:30, 32 minutes ago Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders
Published on 11/02/2026 at 13:30, 32 minutes ago Predictiv AI Awarded Metrolinx Master Agreement for On-Demand Transit Software and Related Services
Published on 11/02/2026 at 13:00, 1 hour 2 minutes ago International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
Published on 11/02/2026 at 13:00, 1 hour 2 minutes ago Bocana Resources Corp. provides an Update on the Proposed Transaction with London Gold LLC
Published on 11/02/2026 at 13:20, 42 minutes ago Westpac 2026 Presentation and Investor Discussion Pack
Published on 11/02/2026 at 13:19, 43 minutes ago Westpac 2026 Full Year Results email to shareholders
Published on 10/30/2026 at 23:00, 2 days 15 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 18:00, 2 days 20 hours ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 3 days 2 hours ago Capital increase through exercise of subscription rights
